Question 1

Which countries lead Ocular Surface and Contact Lens research?

Accepted Answer

By volume, China and the United States publish the most (1.5k and 1.2k works in 2022-now).

Question 2

Which institutions lead Ocular Surface and Contact Lens research?

Accepted Answer

By volume in 2022-now, L V Prasad Eye Institute publishes the most Ocular Surface and Contact Lens research, followed by Wenzhou Medical University and Harvard University.

Question 3

Who are the leading researchers in Ocular Surface and Contact Lens?

Accepted Answer

The most-cited researchers publishing on Ocular Surface and Contact Lens include Jost Bruno Jonas, Shizuo Akira and Gordon Henry Guyatt.

Question 4

Where is Ocular Surface and Contact Lens research done?

Accepted Answer

The largest centres of Ocular Surface and Contact Lens research in 2022-now are Beijing (China), Shanghai (China), Seoul (South Korea) and Moscow (Russia). Among places with at least 20 works in it, it is an unusually large share of all research in Wenzhou.

Question 5

Where is the best place to study Ocular Surface and Contact Lens?

Accepted Answer

Among universities, judged by research, Wenzhou Medical University, Birla Institute of Technology and Science, Pilani and Shenyang Pharmaceutical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is Ocular Surface and Contact Lens research growing?

Accepted Answer

Output in 2022-2025 was 11% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Ocular Surface and Contact Lens.

Question 7

What are the most cited papers in Ocular Surface and Contact Lens?

Accepted Answer

The most cited paper in Ocular Surface and Contact Lens is "Highly stretchable and tough hydrogels" (Jeong‐Yun Sun, Xuanhe Zhao, Widusha R. K. Illeperuma et al., 2012), with 5,503 citations. Next come "Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys" (4,266) and "The Ocular Hypertension Treatment Study" (3,729).